IFNG and neoplasm: The induction of IFN-γ was tumor specific as no increase of IFN-γ levels was seen in either blood or spleen NK cells, demonstrating that 22.0405.aF activates NK cells to release IFN-γ only in the tumor environment and not systemically (Figure 5D).